Milestone Pharmaceuticals Inc (MIST) stock news · $160.6M cap
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
This MIST news page leads with what Milestone Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for MIST yet. We will not pad this page with generic market recap.
Latest reported MIST revenue for 2026-06-30 was $559.0K. Net income was -$28.6M. MIST currently screens at market cap $160.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MIST stock page; for the tape open the quote page.
MIST stock news FAQ
What are MIST's latest revenue and net income?
Latest cached Milestone Pharmaceuticals Inc (MIST) revenue for Jun 30, 2026 was $559.0K. Net income was -$28.6M. Statements: https://lician.com/financials/mist
What is MIST's market cap?
Milestone Pharmaceuticals Inc (MIST) market cap is $160.6M on the latest cached fundamentals snapshot.
What kind of company is MIST?
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Where is MIST stock news listed?
Cached stock news for Milestone Pharmaceuticals Inc (MIST) is listed at https://lician.com/news/mist. Filings: https://lician.com/sec/mist
Not investment advice.